You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TACE failure

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Non-resectable Trial in France (Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Bordeaux, France
  • +5 more
Jun 12, 2023

Unresectable Hepatocellular Carcinoma Trial in Beijing (Camrelizumab, HAIC, TKI)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 22, 2021

Hepatocellular Carcinoma Trial (Hepatic Artery Infusion Chemotherapy, Transarterial Chemoembolization, Regorafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Hepatic Artery Infusion Chemotherapy
  • +3 more
  • (no location specified)
Feb 7, 2022

Hepatocellular Carcinoma Trial in China, Japan (Atezolizumab, Becavizumab, Transarterial chemoembolization (TACE))

Recruiting
  • Hepatocellular Carcinoma
  • Beijing City, China
  • +39 more
Jul 25, 2022

Hepatocellular Carcinoma Trial in Nanjing (Camrelizumab, TACE, Apatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Nanjing, Jiangsu, China
    Zhongda Hospital
Sep 8, 2022

Liver Metastasis Colon Cancer Trial in Guangzhou (TACE and HAIC Combined With Regorafenib)

Not yet recruiting
  • Liver Metastasis Colon Cancer
  • TACE and HAIC Combined With Regorafenib
  • Guangzhou, Guangdong, China
    the first affiliated hospital, Sun-Yat sen university
Oct 2, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Bevacizumab combined with Sintilimab, Transcatheter arterial chemoembolization)

Recruiting
  • Hepatocellular Carcinoma
  • Bevacizumab combined with Sintilimab
  • Transcatheter arterial chemoembolization
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Oct 14, 2023

Carcinoma, Hepatocellular, Hepatic Carcinoma, Hepatocellular Cancer Trial in Hannover (Nivolumab, TACE)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Nov 21, 2022

Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Nov 16, 2021

Hepatocellular Carcinoma Non-resectable, Transarterial Chemoembolization, Tyrosine Kinase Inhibitor Trial in Chengdu (lenvatinib

Enrolling by invitation
  • Hepatocellular Carcinoma Non-resectable
  • +3 more
  • lenvatinib + sindilimab/carrelizumab
  • TACE
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
May 23, 2022

Hepatocellular Carcinoma, Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma Trial in Dallas (Atezolizumab and

Not yet recruiting
  • Hepatocellular Carcinoma
  • Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
  • Atezolizumab and bevacizumab
  • transarterial chemoembolization (TACE) or transarterial radioembolization (TARE
  • Dallas, Texas
    Simmons Comprehensive Cancer Center at University of Texas South
Sep 9, 2022

HCC Trial in Hong Kong (procedure, radiation, drug)

Active, not recruiting
  • HCC
  • TACE
  • +2 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Oct 24, 2022

Hepatocellular Carcinoma Trial in Delhi (DEB, SBRT)

Recruiting
  • Hepatocellular Carcinoma
  • Delhi, NCT, India
    Medanta
Nov 19, 2021

Hepatocellular Carcinoma Trial in London (Stereotactic Body Radiation, Transarterial Chemoembolization)

Recruiting
  • Hepatocellular Carcinoma
  • Stereotactic Body Radiation
  • Transarterial Chemoembolization
  • London, Ontario, Canada
    London Health Sciences Centre, London Regional Cancer Program
Nov 10, 2021

Hepatocellular Carcinoma Trial in Germany, Spain (Atezolizumab, Bevacizumab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Aachen, Germany
  • +8 more
Dec 20, 2021

Carcinoma, Hepatocellular Trial (Regorafenib in combination with nivolumab, Transarterial Chemoembolization (TACE))

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Regorafenib in combination with nivolumab
  • Transarterial Chemoembolization (TACE)
  • (no location specified)
Dec 8, 2021

Hepatocellular Carcinoma Trial in Houston (Lenvatinib, Transcatheter Arterial Chemoembolization)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Houston, Texas
    Houston Methodist Research Institute
Dec 10, 2021

Biliary Tract Tumors, Liver Cancer, Hepatocellular Carcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Trans-arterial

Active, not recruiting
Has Results
  • Biliary Tract Neoplasms
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 1, 2022

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (Sin-Bev-TACE, Len-TACE)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Aug 2, 2023

Hepatocellular Carcinoma Trial in Guangzhou, Kaiping (HAIC of FOLFOX, Sorafenib)

Unknown status
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
  • +2 more
Dec 3, 2020

Carcinoma, Hepatocellular Trial in Irvine, Portland, Milwaukee (Tirapazamine, Doxorubicin)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Irvine, California
  • +2 more
Jan 6, 2021

Hepatocellular Carcinoma Trial in Brussels (Radioembolization using Holmium-166)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Radioembolization using Holmium-166
  • Brussels, Anderlecht, Belgium
    Hôpital Universitaire Erasme, ULB
Dec 7, 2022

Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Nanjing (Oxycodone, Sufentanil)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 15, 2023

HepaSphere Drug-eluting Bead Transarterial Chemoembolization

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • DEB-TACE plus HAIC or HAIC alone
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 19, 2023

Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor Thrombus Trial (I-125 Seeds Brachytherapy in PVTT,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • I-125 Seeds Brachytherapy in PVTT
  • +2 more
  • (no location specified)
Aug 14, 2023